HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

Abstract
The incidence of cutaneous melanoma is steadily increasing. Although several molecular abnormalities have been associated with melanoma progression, the mechanisms underlying the differential gene expression are still largely unknown and targeted therapies are not yet available. Noncoding small RNAs, termed microRNAs (miR), have been recently reported to play important roles in major cellular processes, including those involved in cancer development and progression. We have identified the promyelocytic leukemia zinc finger (PLZF) transcription factor as a repressor of miR-221 and miR-222 by direct binding to their putative regulatory region. Specifically, PLZF silencing in melanomas unblocks miR-221 and miR-222, which in turn controls the progression of the neoplasia through down-modulation of p27Kip1/CDKN1B and c-KIT receptor, leading to enhanced proliferation and differentiation blockade of the melanoma cells, respectively. In vitro and in vivo functional studies, including the use of antisense "antagomir" oligonucleotides, confirmed the key role of miR-221/-222 in regulating the progression of human melanoma; this suggests that targeted therapies suppressing miR-221/-222 may prove beneficial in advanced melanoma.
AuthorsFederica Felicetti, M Cristina Errico, Lisabianca Bottero, Patrizia Segnalini, Antonella Stoppacciaro, Mauro Biffoni, Nadia Felli, Gianfranco Mattia, Marina Petrini, Mario P Colombo, Cesare Peschle, Alessandra Carè
JournalCancer research (Cancer Res) Vol. 68 Issue 8 Pg. 2745-54 (Apr 15 2008) ISSN: 1538-7445 [Electronic] United States
PMID18417445 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CDKN1B protein, human
  • Intracellular Signaling Peptides and Proteins
  • Kruppel-Like Transcription Factors
  • MIRN221 microRNA, human
  • MIRN222 microRNA, human
  • MicroRNAs
  • Oligonucleotides, Antisense
  • Promyelocytic Leukemia Zinc Finger Protein
  • Cyclin-Dependent Kinase Inhibitor p27
  • ZBTB16 protein, human
  • Proto-Oncogene Proteins c-kit
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic (genetics)
  • Cyclin-Dependent Kinase Inhibitor p27
  • Disease Progression
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • Kruppel-Like Transcription Factors (metabolism)
  • Melanoma, Experimental (genetics)
  • Mice
  • Mice, Nude
  • MicroRNAs (genetics)
  • Oligonucleotides, Antisense (pharmacology)
  • Promyelocytic Leukemia Zinc Finger Protein
  • Proto-Oncogene Proteins c-kit (genetics, metabolism)
  • Skin Neoplasms (genetics)
  • Zinc Fingers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: